Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 21Lymphoma, Mantle-Cell 13Lymphoma, Non-Hodgkin 10Lymphoma, Large B-Cell, Diffuse 10Waldenstrom Macroglobulinemia 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Neoplasms 4Leukemia, B-Cell 4Lymphoma, B-Cell 3Burkitt Lymphoma 3Recurrence 2Leukemia, Prolymphocytic 2Leukemia, Lymphoid 2Leukemia, Hairy Cell 2Leukemia 2Hematologic Diseases 2Bronchiolitis Obliterans Syndrome 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms, Castration-Resistant 1Primary Central Nervous System Lymphoma (PCNSL) 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Lymphoma, AIDS-Related 1Lymphatic Diseases 1Leukemia, Prolymphocytic, B-Cell 1

Interventions

prednylidene 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1ibrutinib 1deltacortene 1Vincristine 1Rituximab 1Prednisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, AIDS-Related × ibrutinib × 90 days × Clear all
NCT03220022 2026-04-13

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

National Cancer Institute (NCI)

Phase 1 Active not recruiting
46 enrolled 19 charts
Lymphoid

Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡